Patricia A. Seymour - Concepedia

Author

Patricia A. Seymour

Also Known As

, P A Seymour, P. A. SEYMOUR, P. Seymour, Patricia A Seymour, Patricia A. Seymour, Patricia Seymour, Seymour, Patricia A.

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)Yale University VA Connecticut Healthcare System

About

Patricia A. Seymour is an author at Pfizer (United States) specializing in medicine, social sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.2K
2	Social Sciences	11	11	953
3	Health Sciences	1	1	27
4	Behavioral Sciences	1	1	36
5	Biochemistry	1	1	40

Patricia A. Seymour

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
4-Amino[1,2,4]triazolo[4,3-a]quinoxalines. A novel class of potent adenosine receptor antagonists and potential rapid-onset antidepressants Reinhard Sarges, Harry Howard, Ronald G. Browne, Journal of Medicinal Chemistry	1990	407
Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5 Michael K. Ahlijanian, Nestor X. Barrezueta, Robert D. Williams, Proceedings of the National Academy of Sciences Molecular BiologyCell DeathCytoskeletonCellular PhysiologySocial Sciences	2000	335
CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity Judith A. Siuciak, Douglas S. Chapin, Sheryl A. McCarthy, Neuropharmacology NeuropsychologyPsychoactive DrugPsychiatryMedicinePsychopharmacology	2006	131
Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition Hans Rollema, Mihály Hajós, Patricia A. Seymour, Biochemical Pharmacology Molecular PharmacologyMedicineAffective NeurosciencePsychopharmacologyNeuropharmacology	2009	115
3-Benzisothiazolylpiperazine Derivatives as Potential Atypical Antipsychotic Agents Harry Howard, John Lowe, Thomas Seeger, Journal of Medicinal Chemistry Medicinal ChemistryVivo 8EPsychoactive Drug3-Benzisothiazolylpiperazine DerivativesPsychiatry	1996	90
Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect Hans Rollema, Victor Guanowsky, Yann S. Mineur, European Journal of Pharmacology Antidepressant-like ActivityPsychiatryMedicineDepressionPsychopharmacology	2009	85
The effects of continuous administration of murine interleukin-1α in the rat Ivan G. Otterness, Patricia A. Seymour, Harry Golden, Physiology & Behavior InflammationCytokinePhysiologyImmune RegulationImmunology	1988	84
Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo Robin J. Kleiman, Douglas S. Chapin, Curt Christoffersen, Journal of Pharmacology and Experimental Therapeutics	2012	79
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptor. Stafford McLean, Alan H. Ganong, Patricia A. Seymour, Journal of Pharmacology and Experimental Therapeutics	1996	74
Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists Brooke M. Roberts, Patricia A. Seymour, Christopher J. Schmidt, Psychopharmacology Memory DeficitsCognitive ScienceMedicineNeurotransmitterPsychopharmacology	2010	56

Page 1